Iguana Healthcare Management’s Ionis Pharmaceuticals IONS Stock Holding History

Iguana Healthcare Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40,000	Closed	-$2.01M	–	66
2017 Q4	$2.01M	Buy	40,000 +25,000	+167%	+$1.37M	1.31%	27
2017 Q3	$761K	Buy	+15,000	New	+$786K	0.41%	58
2016 Q4	–	Sell	-100,000	Closed	-$3.66M	–	71
2016 Q3	$3.66M	Buy	+100,000	New	+$3.13M	0.65%	49
2015 Q3	–	Sell	-50,000	Closed	-$2.88M	–	78
2015 Q2	$2.88M	Buy	+50,000	New	+$3.18M	0.91%	36
2014 Q4	–	Sell	-85,000	Closed	-$3.3M	–	66
2014 Q3	$3.3M	Sell	85,000 -50,000	-37%	-$1.77M	1.76%	16
2014 Q2	$4.65M	Buy	+135,000	New	+$4.25M	2.17%	12

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Iguana Healthcare Management's IONS Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2018, closing a stake of 40,000 shares — an estimated $2.01M sold.

Iguana Healthcare Management first reported a position in IONS in Q2 2014 and held it in 6 quarters. The position peaked at $4.65M in Q2 2014. 326 funds tracked by Wall St. Rank hold IONS as of Q1 2018.

Iguana Healthcare Management reported no remaining Ionis Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 40,000 Ionis Pharmaceuticals shares in Q1 2018, an estimated $2.01M.
Iguana Healthcare Management first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 6 quarters.
Iguana Healthcare Management's Ionis Pharmaceuticals position peaked at $4.65M in Q2 2014.
326 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.